Syngenta among options for Monsanto takeover bids: executives
ST. LOUIS (Reuters) – Monsanto Co. executives are discussing whether the world’s largest seed company should acquire agrochemical rivals, including top pesticide maker Syngenta AG , Monsanto President Brett Begemann said on Tuesday.
Wall Street gives up gains after Germany bomb scare
(Reuters) – U.S. stocks forfeited gains on Tuesday after a soccer match between Germany and the Netherlands was called off over fears of a bombing.
White House threatens veto of rule-based monetary policy bill
WASHINGTON (Reuters) – The White House on Tuesday issued a veto threat for a Republican-backed bill to make the Federal Reserve set interest rate policy using a mathematical rule, a proposal Fed Chair Janet Yellen said would “severely damage” the U.S. …
Wal-Mart earnings beat expectations; shares up
(Reuters) – Wal-Mart Stores Inc reported slightly stronger-than-expected quarterly earnings on Tuesday as it booked its fifth straight gain in U.S. same-store sales, sending its shares up more than 4 percent.
U.S. inflation turning corner; factory output rises
WASHINGTON (Reuters) – U.S. consumer prices increased in October after two straight months of declines as the cost of healthcare and other services rose, evidence of firming inflation that further supports views that the Federal Reserve will raise inte…
In U.S. driver lawsuit, Uber must live with class action order for now
SAN FRANCISCO (Reuters) – A U.S. appeals court on Tuesday denied ride service Uber’s request to immediately appeal an order approving class certification in a lawsuit filed by drivers who wish to be deemed employees.
U.S. pursuing criminal cases against RBS, JPMorgan executives: WSJ
(Reuters) – Federal prosecutors are pursuing criminal cases against executives from the Royal Bank of Scotland Group and JPMorgan Chase & Co for allegedly selling flawed mortgage securities, the Wall Street Journal reported on Tuesday, citing unnamed sources.
Top healthcare stock fund focuses on costs, orphan drugs in 2016
NEW YORK (Reuters) – Healthcare companies that can either contain costs or develop medications to treat rare diseases, known as orphan drugs, will be the most likely to outperform in the coming year, said John Fraunces, whose Turner Medical Sciences Lo…
Einhorn’s Greenlight takes new long positions, exits some shorts: letter
BOSTON (Reuters) – Billionaire investor David Einhorn, whose Greenlight Capital hedge fund is nursing a 17 percent loss this year, told investors on Wednesday that he made new bets on fashion company Michael Kors and electric services company UIL Holdi…
American Airlines to reward fliers for money spent, not mileage flown
(Reuters) – American Airlines Group Inc on Tuesday said it will change its loyalty program in the second half of next year so customers earn frequent-flier miles based on the fares they pay rather than the distance they fly.
